Cancer reduces transcriptome specialization.
A central goal of cancer biology is to understand how cells from this family of genetic diseases undergo specific morphological and physiological changes and regress to a de-regulated state of the cell cycle. The fact that tumors are unable to perform most of the specific functions of the original tissue led us to hypothesize that the degree of specialization of the transcriptome of cancerous tissues must be less than their normal counterparts. With the aid of information theory tools, we analyzed four datasets derived from transcriptomes of normal and tumor tissues to quantitatively test the hypothesis that cancer reduces transcriptome specialization. Here, we show that the transcriptional specialization of a tumor is significantly less than the corresponding normal tissue and comparable with the specialization of dedifferentiated embryonic stem cells. Furthermore, we demonstrate that the drop in specialization in cancerous tissues is largely due to a decrease in expression of genes that are highly specific to the normal organ. This approach gives us a better understanding of carcinogenesis and offers new tools for the identification of genes that are highly influential in cancer progression.
Martínez
Octavio
O
Laboratorio Nacional de Genómica para la Biodiversidad, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Irapuato, Guanajuato, México. omartine@ira.cinvestav.mx
Reyes-Valdés
M Humberto
MH
Herrera-Estrella
Luis
L
D000818:Animals; D030541:Databases, Genetic; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D052138:Genes, Neoplasm / Q000235:genetics; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000235:genetics*
Cancer Cell. 2002 Feb;1(1):3-10
12086880
Eur J Biochem. 2004 Aug;271(16):3368-78
15291814
Cancer Res. 2002 Jul 1;62(13):3883-7
12097304
Cancer Res. 2005 Feb 1;65(3):919-24
15705891
J Biol Chem. 2004 Apr 23;279(17):17278-82
15001576
Science. 2007 Jul 20;317(5836):337
17641192
Environ Health Perspect. 1993 Dec;101 Suppl 5:15-26
7516873
Hum Mol Genet. 2001 Apr;10(7):663-7
11257097
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9309-14
15184677
Expert Opin Ther Targets. 2003 Dec;7(6):759-69
14640911
Nat Rev Cancer. 2008 Jan;8(1):56-61
18059462
Cancer Res. 2005 Jun 15;65(12):4993-7
15958538
Nature. 2004 Nov 18;432(7015):324-31
15549094
Nat Genet. 2006 Apr;38(4):468-73
16565718
Biochem Biophys Res Commun. 2008 Jan 11;365(2):221-6
17980147
Hum Pathol. 2007 May;38(5):702-9
17376511
Am J Pathol. 2007 Jul;171(1):252-62
17591970
Nat Cell Biol. 2004 Nov;6(11):1135-41
15502821
Crit Rev Oncol Hematol. 2004 Jul;51(1):1-28
15207251
Biomedica. 2007 Jun;27(2):190-203
17713630
Nucleic Acids Res. 2008 Dec;36(21):e141
18927111
Nature. 2001 Nov 1;414(6859):105-11
11689955
Nat Genet. 2008 May;40(5):499-507
18443585
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3396-401
19218430
Science. 2001 Feb 16;291(5507):1289-92
11181992
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13418-23
14593198
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9709-14
18606989